α5 integrin distribution and TGFβ1 gene expression in supraglottic carcinoma: Their role in neoplastic local invasion and metastasis

Head and Neck

Volumn 22, Issue 1, 2000, Pages 48-56

  Vitolo, Domenico ^a   Ciocci, Luciano ^a   Ferrauti, Paola ^a   Cicerone, Elena ^a   Gallo, Andrea ^a   De Vincentiis, Marco ^a   Baroni, Carlo D ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

5; Supraglottic carcinoma; Tenascin; TGF 1

Indexed keywords

AMINO ACID; BETA GLOBIN; CELL ADHESION MOLECULE; COLLAGEN TYPE 4; CYTOKINE; FIBRONECTIN; GAMMA INTERFERON; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1; ALPHA5 INTEGRIN; LEUKOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

AMINO ACID SEQUENCE; ARTICLE; CANCER INVASION; CELL INTERACTION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; CARCINOMA IN SITU; COMPARATIVE STUDY; CULTURE TECHNIQUE; FEMALE; GENETICS; LARYNX TUMOR; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD; BASE SEQUENCE; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CULTURE TECHNIQUES; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA5; INTEGRINS; LARYNGEAL NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 0033622327     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(200001)22:1<48::AID-HED8>3.0.CO;2-L     Document Type: Article

References (47)

1. Fidler, IJ. Critical factors in the biology of human cancer metastasis. Cancer Res 1990;50:6130-6142.
2. Diamond L, O'Brien TG, Bard WM. Tumor promoters and the mechanism of tumor promotion. Adv Cancer Res 1980; 32:1-74.
3. Gillis TM, Incze J, Strong MS, et al. Natural history and management of keratosis, atypia, carcinoma in situ, and microinvasive cancer of the larynx. Am J Surg 1983;146: 512-516.
4. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
5. Albelda SM. Biology of disease: Role of integrins and other adhesion molecules in tumor progression and metastasis. Lab invest 1993;68:4-17.
6. Juliano LR, Varner JA. Adhesion molecules in cancer: the role of integrins. Curr Op Cell Biol 1993;5:812-818.
7. Pignatelli M, Vessey J. Adhesion molecules: Novel molecular tools in tumor pathology. Human Pathol 1994;25: 849-856.
8. Damjanovich L, Albelda SM, Mette SA, Buck CA. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol 1992;6: 197-206.
9. De Luca M, Pellegrini G, Zambruno G, Marchisio PC. Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies J Dermatol 1994; 21:821-828.
10. Gilat D, Cahalon L, Hershkoviz R, Lider O. Interplay of T-cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol Today 1996;17: 16-20.
11. Gould VE, Koukoulis GK, Virtanen I. Extracellular matrix proteins and their receptors in the normal, hyperplastic, and neoplastic breast. Cell Differ Devel 1992;32: 409-416.
12. Satyaswaroop PG, Tabibzadeh SS. Extracellular matrix and the patterns of differentiation of human endometrial carcinomas in vitro and in vivo. Cancer Res 1991;51: 5661-5666.
13. Miettinen M, Castello M, Wayner E, Schwarting R. Distribution of VLA integrins in solid tumors: emergence of tumor-type-related expression patterns in carcinomas and sarcomas. Am J Pathol 1993;142:1009-1018.
14. Perussia B. Tumor infiltrating cells. Lab Invest 1992;67: 155-157.
15. Romagnani S. Induction of Th1 and Th2 responses: A key role for the natural immune response? Immunol Today 1992;13:379-380.
16. Vitolo D, Letessier EM, Johnson JT, Whiteside TL. Immunologic effector cells in head and neck cancer. JNCI Monogr 1992;13:203-208.
17. Vitolo D, Zerbe T, Kanbour A, et al. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 1992;51:573-580.
18. Vitolo D, Kanbour A, Johnson TJ, et al. In situ hybridization for cytokine gene transcripts in the solid tumour microenvironment. Eur J Cancer 1993;29A:371-377.
19. Vitolo D, Palmieri MB, Ruco LP, et al. Cytokine production and expression of adhesion molecules and integrins in tumor infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung. Am J Pathol 1994;145: 322-329.
20. Bradley LM, Yoshimoto K, Swain SL. The cytokines IL-4, IFN-γ, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J Immunol 1995; 155:1713-1724.
21. Shanmugaratnam K, Path FRC, Sobin Leslie H. The World Health Organization, Histological classification of tumors of the upper respiratory tract and ear. A commentary on the second edition. Cancer 1993;71:2689-2697.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
23. Pignatelli M, Cardillo MR, Hanby A, Stamp GW. Integrins and their accessory adhesion molecules in mammary carcinomas: Loss of polarization in poorly differentiated tumors. Human Pathol 1992;23:1159-1166.
24. Jiang TX, Chuong CM. Mechanism of skin morphogenesis. I. Analyses with antibodies to adhesion molecules. Tenascin, N-CAM and Integrin. Dev Biol 1992;150:82-98.
25. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987;238:491-497.
26. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cell with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-4027.
27. Trinchieri G. Interleukin-12 and interferon-γ. Do they always go together? Am J Pathol 1995;147:1534-1538.
28. Tahara H, Zitvogel L, Storkus WJ, et al. Effective eradication of established murine tumors with IL12 gene therapy using a polycistronic retroviral vector. J Immunol 1995;154:6466-6474.
29. Tan J, Newton CA, Djeu YJ, et al. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res 1996;56:3399-3403.
30. Rabinowich H, Vitolo D, Altarac S, et al. Role of cytokines in the adoptive immuunotherapy of an experimental model of human head and neck cancer by human IL-2-activated killer cells. J Immunol 1992;149:340-349.
31. Macatonia SE, Hosken NA, Litton A, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071-5079.
32. Nickoloff BJ, Mitra RS, Green J, et al. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J Immunol 1993;150: 2148-2159.
33. Fausto N. Multifunctional roles of transforming growth factor β1, Lab Invest 1991;65:497-499.
34. Truong LD, Kadmon D, McKune BK, et al. Association of transforming growth factor β1 with prostate cancer: an immunohistochemical study. Human Pathol 1995;24:4-9.
35. Zambruno G, Marchisio PC, Marconi A, et al. Transforming growth factor β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the αv-β6 heterodimer in normal human keratinocytes: implication for wound healing. J Cell Biol 1995;129:853-865.
36. Zagzag D. Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 1995;146:293-308.
37. Ruegg CR, Chiquet-Ehrismann R, Alkan SS. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 1989;86:7437-7441.
38. Adachi M, Taki T, Ogawa E, et al. Expression of integrin alpha3 and alpha5 are associated with prognosis of non-small cell lung cancer (NSCLC). Proceedings of the 88th Annual Meeting of the American Association for Cancer Research, April 12-16, San Diego, CA, 1997;38:329.
39. Takizawa T, Nishinarita S, Kitamura N, et al. Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured monocytes. Clin Exp Immunol 1995;105:376-382.
40. Damsky C, Tremble P, Werb E. Signal transduction via the fibronectin receptor: do integrins regulate matrix remodelling? Matrix Supp 1992;1:184-191.
41. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrofoblast differentiation along the invasive pathway, in vivo. J Clin Invest 1992;89:210-222.
42. Anbazhagan R, Sakakura T, Gusterson BA. The distribution of immunoreactive tenascin in the epithelialmesenchimal junction areas of benign and malignant squamous epithelia. Virchows Arch B Cell Pathol 1990; 59:59-63.
43. Howeedy Aly A, Virtanen I, Laitinen L, et al. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 1990;63:798-806.
44. Juhasz I, Murphy GF, Yan HC, et al. Regulation of extracellular matrix proteins and integrin cells substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. Am J Pathol 1993;143:1458-1469.
45. Koukoulis GK, Gould VE, Bhattacharyya A, et al. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: Biologic and pathologic implication. Human Pathol 1991;22:636-643.
46. Koukoulis GK, Virtanen I, Korhonen M, et al. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 1991;139: 787-799.
47. Whitby DJ, Longaker MT, Harrison MR, et al. Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin. J Cell Sci 1991;99:583-586.